AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Progress reported in smallpox vaccine development.
2004 SEP 20 - (NewsRx.com & NewsRx.net) -- International biopharmaceutical company Bavarian Nordic announced key developments.
Bavarian Nordic noted particular progress has been made to date on their safe, third generation smallpox vaccine program in the U.S.:
1) The U.S. Food and Drug Administration (FDA) granted Bavarian Nordic an Investigational New Drug (IND) application for Imvamune to enter further clinical trials. The first-ever trial with Imvamune in persons with atopic disorders (ie. eczema) is underway.
2) Results from a phase II study showed that Imvamune has an excellent safety profile at all three dose levels tested. All study volunteers sero-converted after two vaccinations at all doses.
3) Bavarian Nordic submitted its proposal on RFP-2 to the National Institute of Health (NIH) in February. The award announcement is expected in September 2004.
4) Global manufacturing and marketing collaboration with GlaxoSmithKline on Imvamune established.
5) The U.S. Patent and Trademark Office (PTO) issued a patent to Bavarian Nordic on MVA-BN. The patent covers the MVA-BN virus and derivatives thereof exhibiting similar properties, including its use as a smallpox vaccine (Imvamune), and vector technology for development of recombinant vaccines for the prevention and treatment of other diseases.
- IMVAMUNE(TM) Vaccine - Protection Against Smallpox in 3 Days; Bavarian Nordic...
- Press release article from: PR Newswire February 24, 2005 700+ words
...and clinical trials, Bavarian Nordic expects IMVAMUNE(TM) to be effective...Development and Production Bavarian Nordic's global IMVAMUNE(TM) smallpox vaccine...more information about Bavarian Nordic and IMVAMUNE(TM) please visit...
- Bavarian Nordic Announces Major Accomplishments in Safe Smallpox Vaccine...
- Press release article from: PR Newswire March 7, 2005 700+ words
...President and CEO of Bavarian Nordic. "IMVAMUNE(TM) has shown...derivatives thereof, IMVAMUNE(TM) (Bavarian Nordic's smallpox vaccine...government to develop IMVAMUNE(TM) as a safe...smallpox vaccine. Bavarian Nordic's advanced clinical...
- Bavarian Nordic and GlaxoSmithKline Enter Into Global Collaboration on IMVAMUNE.
- Press release article from: PR Newswire July 15, 2004 700+ words
...production and marketing of Bavarian Nordic's smallpox vaccine IMVAMUNE(TM), which is based on Bavarian Nordic's proprietary MVA-BN...global collaboration on IMVAMUNE(TM). www.bavarian-nordic.com Bavarian Nordic...
- Bavarian Nordic and GlaxoSmithKline Enter into Global Collaboration on IMVAMUNE.
- Press release article from: Business Wire July 15, 2004 700+ words
...and marketing of Bavarian Nordic's smallpox vaccine IMVAMUNE(TM), which is based on Bavarian Nordic's proprietary MVA...Britain and France. Bavarian Nordic will continue to manufacture and market IMVAMUNE(TM) to all German...
- Bavarian Nordic Reports Positive Data From First EUA Enabling Study With...
- Press release article from: PR Newswire November 29, 2007 700+ words
...FirstCall/ -- Bavarian Nordic reports the successful...or two doses of IMVAMUNE(R) next-generation...II studies with IMVAMUNE(R) in immune...Authorization (EUA). Bavarian Nordic expects to receive...development of IMVAMUNE(R) as the modern...vaccine." About Bavarian ...
- Bavarian Nordic Reports Positive Data from First EUA Enabling Study with...
- Press release article from: PR Newswire November 29, 2007 700+ words
...FirstCall/ -- Bavarian Nordic reports the successful...or two doses of IMVAMUNE(R) next-generation...II studies with IMVAMUNE(R) in immune...Authorization (EUA). Bavarian Nordic expects to receive...development of IMVAMUNE(R) as the modern...vaccine." About Bavarian ...
- IMVAMUNE Selected as Brand Name for Bavarian Nordic's MVA-BN Smallpox Vaccine;...
- Press release article from: PR Newswire March 30, 2004 700+ words
...will refer to the new brand name IMVAMUNE(tm). Bavarian Nordic also confirms that re-construction...reference. StockWise resume: Bavarian Nordic selects IMVAMUNE(tm) as brand name for Bavarian Nordic's MVA-BN smallpox vaccine...
- US FDA Grants IND to Bavarian Nordic, Trial with IMVAMUNE Smallpox Vaccine in...
- Press release article from: PR Newswire May 5, 2004 700+ words
...clinical trials. Bavarian Nordic will immediately...Phase l study with IMVAMUNE(TM), its safe...will investigate IMVAMUNE (TM) in people with HIV. While Bavarian Nordic has already conducted...StockWise resume: Bavarian Nordic receives IND from...clinical trials with ...
- IMVAMUNE Selected as Brand Name for Bavarian Nordic's MVA-BN Smallpox Vaccine;...
- Press release article from: PR Newswire March 30, 2004 700+ words
...will refer to the new brand name IMVAMUNE(tm). Bavarian Nordic also confirms that re-construction...reference. StockWise resume: Bavarian Nordic selects IMVAMUNE(tm) as brand name for Bavarian Nordic's MVA-BN smallpox vaccine...
- Bavarian Nordic Awarded a USD 100 Million Contract From US Government to...
- Press release article from: PR Newswire Europe September 30, 2004 700+ words
...today awarded Bavarian Nordic A/S a three...its patented IMVAMUNE(TM) as...thereof, IMVAMUNE(TM) (Bavarian Nordic's smallpox...StockWise resume: Bavarian Nordic awarded a...further develop IMVAMUNE(TM) as...
Source: HighBeam Research, Progress reported in smallpox vaccine development.